{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:02:01Z","timestamp":1789639321261,"version":"4.0.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82530106"],"award-info":[{"award-number":["82530106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77659-x","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:29Z","timestamp":1789635809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic Basis for 5-HT2AR Over 5-HT2BR Activation"],"prefix":"10.1038","volume":"17","author":[{"given":"Lingjie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-386X","authenticated-orcid":false,"given":"Licong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-2682","authenticated-orcid":false,"given":"Jianjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4176-8844","authenticated-orcid":false,"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"77659_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1177\/0269881116679368","volume":"30","author":"JJ Rucker","year":"2016","unstructured":"Rucker, J. J., Jelen, L. A., Flynn, S., Frowde, K. D. & Young, A. H. Psychedelics in the treatment of unipolar mood disorders: a systematic review. J. Psychopharmacol. 30, 1220\u20131229 (2016).","journal-title":"J. Psychopharmacol."},{"key":"77659_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1021\/acs.chemrev.3c00375","volume":"124","author":"W Duan","year":"2024","unstructured":"Duan, W., Cao, D., Wang, S. & Cheng, J. Serotonin 2A receptor (5-HT(2A)R) agonists: psychedelics and non-hallucinogenic analogues as emerging antidepressants. Chem. Rev. 124, 124\u2013163 (2024).","journal-title":"Chem. Rev."},{"key":"77659_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fpsyt.2019.00943","volume":"10","author":"JJ Fuentes","year":"2019","unstructured":"Fuentes, J. J., Fonseca, F., Elices, M., Farre, M. & Torrens, M. Therapeutic use of LSD in psychiatry: a systematic review of randomized-controlled clinical trials. Front. Psychiatry 10, 943 (2019).","journal-title":"Front. Psychiatry"},{"key":"77659_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris, R. L. et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3, 619\u2013627 (2016).","journal-title":"Lancet Psychiatry"},{"key":"77659_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","volume":"78","author":"AK Davis","year":"2021","unstructured":"Davis, A. K. et al. Effects of psilocybin-assisted therapy on major depressive disorder: a Randomized Clinical Trial. JAMA Psychiatry 78, 481\u2013489 (2021).","journal-title":"JAMA Psychiatry"},{"key":"77659_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson, M. W., Garcia-Romeu, A. & Griffiths, R. R. Long-term follow-up of psilocybin-facilitated smoking cessation. Am. J. Drug Alcohol Abuse 43, 55\u201360 (2017).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"77659_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris, R. et al. Trial of psilocybin versus escitalopram for depression. N. Engl. J. Med. 384, 1402\u20131411 (2021).","journal-title":"N. Engl. J. Med."},{"key":"77659_CR8","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin, G. M. et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N. Engl. J. Med. 387, 1637\u20131648 (2022).","journal-title":"N. Engl. J. Med."},{"key":"77659_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.2023.14530","volume":"330","author":"CL Raison","year":"2023","unstructured":"Raison, C. L. et al. Single-dose psilocybin treatment for major depressive disorder: a Randomized Clinical Trial. JAMA 330, 843\u2013853 (2023).","journal-title":"JAMA"},{"key":"77659_CR10","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.eclinm.2022.101809","volume":"56","author":"R von Rotz","year":"2023","unstructured":"von Rotz, R. et al. Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial. EClinicalMedicine 56, 101809 (2023).","journal-title":"EClinicalMedicine"},{"key":"77659_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","volume":"181","author":"D Nutt","year":"2020","unstructured":"Nutt, D., Erritzoe, D. & Carhart-Harris, R. Psychedelic psychiatry\u2019s brave new world. Cell 181, 24\u201328 (2020).","journal-title":"Cell"},{"key":"77659_CR12","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2025.13481","volume":"334","author":"R Robison","year":"2025","unstructured":"Robison, R. et al. Single treatment with MM120 (Lysergide) in generalized anxiety disorder: a Randomized Clinical Trial. JAMA 334, 1358\u20131372 (2025).","journal-title":"JAMA"},{"key":"77659_CR13","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen, M. K. et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology 44, 1328\u20131334 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"77659_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","volume":"27","author":"KH Preller","year":"2017","unstructured":"Preller, K. H. et al. The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Curr. Biol. 27, 451\u2013457 (2017).","journal-title":"Curr. Biol."},{"key":"77659_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44016-1","volume":"14","author":"J Wallach","year":"2023","unstructured":"Wallach, J. et al. Identification of 5-HT(2A) receptor signaling pathways associated with psychedelic potential. Nat. Commun. 14, 8221 (2023).","journal-title":"Nat. Commun."},{"key":"77659_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso, J. et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53, 439\u2013452 (2007).","journal-title":"Neuron"},{"key":"77659_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-025-08813-6","volume":"642","author":"LX Shao","year":"2025","unstructured":"Shao, L. X. et al. Psilocybin\u2019s lasting action requires pyramidal cell types and 5-HT(2A) receptors. Nature 642, 411\u2013420 (2025).","journal-title":"Nature"},{"key":"77659_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","volume":"589","author":"LP Cameron","year":"2021","unstructured":"Cameron, L. P. et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589, 474\u2013479 (2021).","journal-title":"Nature"},{"key":"77659_CR19","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.cell.2021.03.043","volume":"184","author":"C Dong","year":"2021","unstructured":"Dong, C. et al. Psychedelic-inspired drug discovery using an engineered biosensor. Cell 184, 2779\u20132792 e18 (2021).","journal-title":"Cell"},{"key":"77659_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.abl8615","volume":"375","author":"D Cao","year":"2022","unstructured":"Cao, D. et al. Structure-based discovery of nonhallucinogenic psychedelic analogs. Science 375, 403\u2013411 (2022).","journal-title":"Science"},{"key":"77659_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","volume":"610","author":"AL Kaplan","year":"2022","unstructured":"Kaplan, A. L. et al. Bespoke library docking for 5-HT(2A) receptor agonists with antidepressant activity. Nature 610, 582\u2013591 (2022).","journal-title":"Nature"},{"key":"77659_CR22","doi-asserted-by":"publisher","first-page":"112203","DOI":"10.1016\/j.celrep.2023.112203","volume":"42","author":"V Lewis","year":"2023","unstructured":"Lewis, V. et al. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Rep 42, 112203 (2023).","journal-title":"Cell Rep"},{"key":"77659_CR23","doi-asserted-by":"crossref","unstructured":"Jain, M.K. et al. The polypharmacology of psychedelics reveals multiple targets for potential therapeutics. Neuron 113, 3129\u20133142. e9 (2025).","DOI":"10.1016\/j.neuron.2025.06.012"},{"key":"77659_CR24","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1056\/NEJM199712113372414","volume":"337","author":"PD Thompson","year":"1997","unstructured":"Thompson, P. D. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337, 1772 (1997). Author reply 1775.","journal-title":"N. Engl. J. Med."},{"key":"77659_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","volume":"57","author":"LW Fitzgerald","year":"2000","unstructured":"Fitzgerald, L. W. et al. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol. Pharmacol. 57, 75\u201381 (2000).","journal-title":"Mol. Pharmacol."},{"key":"77659_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/sj.bjp.0703118","volume":"129","author":"S Rajamani","year":"2000","unstructured":"Rajamani, S., Studenik, C., Lemmens-Gruber, R. & Heistracher, P. Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs. Br. J. Pharmacol. 129, 843\u2013852 (2000).","journal-title":"Br. J. Pharmacol."},{"key":"77659_CR27","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","volume":"102","author":"RB Rothman","year":"2000","unstructured":"Rothman, R. B. et al. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102, 2836\u20132841 (2000).","journal-title":"Circulation"},{"key":"77659_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1056\/NEJMp068265","volume":"356","author":"BL Roth","year":"2007","unstructured":"Roth, B. L. Drugs and valvular heart disease. N. Engl. J. Med. 356, 6\u20139 (2007).","journal-title":"N. Engl. J. Med."},{"key":"77659_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","volume":"132","author":"JD Hutcheson","year":"2011","unstructured":"Hutcheson, J. D., Setola, V., Roth, B. L. & Merryman, W. D. Serotonin receptors and heart valve disease\u2014it was meant 2B. Pharmacol. Ther. 132, 146\u2013157 (2011).","journal-title":"Pharmacol. Ther."},{"key":"77659_CR30","unstructured":"Guidance for Industry. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/psychedelic-drugs-considerations-clinical-investigations."},{"key":"77659_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41594-018-0116-7","volume":"25","author":"JD McCorvy","year":"2018","unstructured":"McCorvy, J. D. et al. Structural determinants of 5-HT2B receptor activation and biased agonism. Nat. Struct. Mol. Biol. 25, 787\u2013796 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77659_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57956-7","volume":"16","author":"RH Gumpper","year":"2025","unstructured":"Gumpper, R. H. et al. The structural diversity of psychedelic drug actions revealed. Nat. Commun. 16, 2734 (2025).","journal-title":"Nat. Commun."},{"key":"77659_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","volume":"168","author":"D Wacker","year":"2017","unstructured":"Wacker, D. et al. Crystal structure of an LSD-bound human serotonin receptor. Cell 168, 377\u2013389. e12 (2017).","journal-title":"Cell"},{"key":"77659_CR34","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","volume":"182","author":"K Kim","year":"2020","unstructured":"Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT(2A) serotonin receptor. Cell 182, 1574\u20131588 e19 (2020).","journal-title":"Cell"},{"key":"77659_CR35","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1016\/j.neuron.2024.07.003","volume":"112","author":"L Fan","year":"2024","unstructured":"Fan, L. et al. Structural basis of psychedelic LSD recognition at dopamine D(1) receptor. Neuron 112, 3295\u20133310 e8 (2024).","journal-title":"Neuron"},{"key":"77659_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","volume":"26","author":"KT Kimura","year":"2019","unstructured":"Kimura, K. T. et al. Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine. Nat. Struct. Mol. Biol. 26, 121\u2013128 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77659_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn6354","volume":"384","author":"J Lyu","year":"2024","unstructured":"Lyu, J. et al. AlphaFold2 structures guide prospective ligand discovery. Science 384, eadn6354 (2024).","journal-title":"Science"},{"key":"77659_CR38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"77659_CR39","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2024.01.028","volume":"187","author":"R Janicot","year":"2024","unstructured":"Janicot, R. et al. Direct interrogation of context-dependent GPCR activity with a universal biosensor platform. Cell 187, 1527\u20131546. e25 (2024).","journal-title":"Cell"},{"key":"77659_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14884-y","volume":"11","author":"L Fan","year":"2020","unstructured":"Fan, L. et al. Haloperidol bound D(2) dopamine receptor structure inspired the discovery of subtype selective ligands. Nat. Commun. 11, 1074 (2020).","journal-title":"Nat. Commun."},{"key":"77659_CR41","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1016\/j.neuron.2022.08.006","volume":"110","author":"C Cao","year":"2022","unstructured":"Cao, C. et al. Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD. Neuron 110, 3154\u20133167 e7 (2022).","journal-title":"Neuron"},{"key":"77659_CR42","doi-asserted-by":"publisher","first-page":"e0175642","DOI":"10.1371\/journal.pone.0175642","volume":"12","author":"R Nehme","year":"2017","unstructured":"Nehme, R. et al. Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS ONE 12, e0175642 (2017).","journal-title":"PLoS ONE"},{"key":"77659_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"77659_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290 (2017).","journal-title":"Nat. Methods"},{"key":"77659_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"77659_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"77659_CR47","unstructured":"Kaplan, A. L. et al. Bespoke library docking for 5-HT2A receptor agonists with anti-depressant activity. Nature (2022)."},{"key":"77659_CR48","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.1073\/pnas.1700891114","volume":"114","author":"A Ishchenko","year":"2017","unstructured":"Ishchenko, A. et al. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody. Proc. Natl. Acad. Sci. USA 114, 8223\u20138228 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77659_CR49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30, 70\u201382 (2021).","journal-title":"Protein Sci"},{"key":"77659_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta. Crystallogr. Sect. D-Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta. Crystallogr. Sect. D-Biol. Crystallogr."},{"key":"77659_CR51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta. Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta. Crystallogr. D"},{"key":"77659_CR52","doi-asserted-by":"publisher","unstructured":"Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.06.14.659707 (2025).","DOI":"10.1101\/2025.06.14.659707"},{"key":"77659_CR53","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/jcc.24829","volume":"38","author":"S Kim","year":"2017","unstructured":"Kim, S. et al. CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules. J. Comput. Chem. 38, 1879\u20131886 (2017).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77659-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77659-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77659-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:32Z","timestamp":1789635812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77659-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77659"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77659-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.W., J.C., L.T., X.J., and H.L. have filed a patent (CN202610216991X) through their institutions for the compounds reported in this study. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9873"}}